Tasly Pharmaceutical Buys 100% of TaslyDiyi Pharma

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

April 22, 2013 -- Tasly Pharmaceutical, a company known mainly for its TCM products, paid 1.5 billion RMB ($240 million) to acquire Jiangsu TaslyDiyi Pharmaceutical, a maker of chemical drugs. TaslyDiyi was 75% owned by Tianjin Tasly Group, Tasly Pharma’s corporate parent. The remaining 25% belonged to Chongshi Ventures. In 2003, Tasly Group and Chongshi Ventures bought Diyi Pharma for 67 million RMB, which means their 10-year holding returned 22 times their initial investment. More details....

Stock Symbol: (SHA: 600535)

Help employers find you! Check out all the jobs and post your resume.